Strong Sales in North America
The EVIS X1 GI endoscopy system drove double-digit growth in North America across all focus areas: GI, urology, and respiratory.
Record Revenue Achievement
Consolidated revenue increased by 8% year-on-year to ¥997.3 billion, marking a record high for both the single quarter and the full year.
Improved Operating Margin
Adjusted operating profit increased by 25% year-on-year to ¥188.5 billion, with an adjusted operating margin improving 2.6 points to 18.9%.
Dividend Increase and Share Buyback
The company plans to pay a dividend of ¥30 per share, up ¥10 from the previous year, and undertake a share buyback of ¥50 billion.
Launch of OLYSENSE and CAD/AI
The company plans to launch the first CAD/AI products of OLYSENSE in Europe and the U.S., with the phased rollout beginning in H2, FY2026.
New CEO Appointment
Bob White will be the new Representative Executive Officer President and CEO effective June 1, bringing extensive industry knowledge and insights to Olympus.